NEW YORK (GenomeWeb News) – Medistem Laboratories will collaborate with Albert Einstein College of Medicine and the Kansas City Veterans Administration to characterize the epigenetic profile of stem cells derived from menstrual blood, the company said today.
Defining the subcellular characteristics of this group of endometrial regenerative cells will help the company translate its in vitro and animal studies into human trials, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.